TG Therapeutics | Ativo Circulante

Current Assets Alterar Data
AbbVie USD 38.87B 5.65B 2024-03
Amgen USD 28.03B 2.3B 2024-03
Ardelyx USD 257.94M 16.72M 2024-03
Arrowhead Research USD 541.65M 303.75M 2024-03
Bayer EUR 40.17B 2.61B 2024-03
Biogen USD 6.76B 103.1M 2024-03
Corcept Therapeutics USD 503.37M 44.73M 2024-03
Dynavax Technologies USD 851.29M 7.83M 2024-03
Gilead Sciences USD 14.04B 2.41B 2024-03
J&J USD 57B 3.3B 2024-03
Novartis USD 26.45B 4.03B 2024-03
PTC Therapeutics USD 1.17B 49.89M 2024-03
Regeneron Pharmaceuticals USD 18.87B 5.62B 2024-03
Roche Holding CHF 33.45B 2.47B 2023-12
TG Therapeutics USD 360.58M 41.47M 2024-03
Vertex Pharmaceuticals USD 13.29B 1.41B 2024-03



TG Therapeutics Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Jun 2024.